The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
reported to
the Securities and Exchange Commission (SEC)
by insider Orbimed Capital Gp V Llc since year 2005.
The trader's CIK number is 1615374.
At the time of the last reporting, Orbimed Capital Gp V Llc was the Officer of Tricida, Inc. .
(stock ticker symbol TCDA).
See this page for all insider trading activities at Tricida, Inc. .
| Trade Date | Symbol | Company Name (Issuer) | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|---|
| 2019-04-03 | TCDA | Tricida, Inc. | Buy | 225,000 | 36.00 | 8,100,000 |
| 2019-03-07 | INSP | Inspire Medical Systems, Inc. | Sale | 68,218 | 55.01 | 3,752,672 |
| 2019-03-08 | INSP | Inspire Medical Systems, Inc. | Sale | 290,231 | 57.75 | 16,760,840 |
| 2018-12-11 | INSP | Inspire Medical Systems, Inc. | Sale | 614,772 | 37.60 | 23,115,427 |
| 2018-10-19 | SIBN | Si-bone, Inc. | Buy | 200,000 | 15.00 | 3,000,000 |
| 2018-07-02 | TCDA | Tricida, Inc. | Buy | 368,421 | 19.00 | 6,999,999 |
| 2018-06-28 | ARPO | Aerpio Pharmaceuticals, Inc. | Buy | 777,500 | 3.85 | 2,993,375 |
| 2018-06-04 | ADAP | Adaptimmune Therapeutics Plc | Sale | 17,100 | 13.57 | 232,047 |
| 2018-06-06 | ADAP | Adaptimmune Therapeutics Plc | Sale | 1,600 | 13.49 | 21,584 |
| 2018-06-01 | ADAP | Adaptimmune Therapeutics Plc | Sale | 50,000 | 13.49 | 674,500 |
| 2018-05-30 | ADAP | Adaptimmune Therapeutics Plc | Sale | 121,000 | 13.52 | 1,635,920 |
| 2018-05-22 | RYTM | Rhythm Pharmaceuticals, Inc. | Sale | 19,580 | 30.67 | 600,518 |
| 2018-05-18 | RYTM | Rhythm Pharmaceuticals, Inc. | Sale | 69,136 | 30.77 | 2,127,314 |
| 2018-05-21 | RYTM | Rhythm Pharmaceuticals, Inc. | Sale | 62,500 | 31.01 | 1,938,125 |
| 2018-05-14 | ADAP | Adaptimmune Therapeutics Plc | Sale | 10,300 | 13.50 | 139,050 |
| 2018-05-07 | INSP | Inspire Medical Systems, Inc. | Buy | 312,500 | 16.00 | 5,000,000 |
| 2018-03-27 | ADAP | Adaptimmune Therapeutics Plc | Sale | 1,016,084 | 11.50 | 11,684,966 |
| 2018-03-29 | ADAP | Adaptimmune Therapeutics Plc | Sale | 31,983 | 11.53 | 368,763 |
| 2018-03-12 | CRVS | Corvus Pharmaceuticals, Inc. | Buy | 588,235 | 8.50 | 4,999,997 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Orbimed Capital Gp V Llc (Officer of Tricida, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.